Difference between revisions of "Types/liver"
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Liver and Bile Duct Cancer == | + | == Liver and Bile Duct Cancer == <!--T:1--> |
Liver cancer includes hepatocellular carcinoma (HCC) and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver. Explore the links on this page to learn more about liver cancer treatment, prevention, screening, statistics, research, and clinical trials. | Liver cancer includes hepatocellular carcinoma (HCC) and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver. Explore the links on this page to learn more about liver cancer treatment, prevention, screening, statistics, research, and clinical trials. | ||
| + | <!--T:2--> | ||
'''PDQ Treatment Information for Patients''' | '''PDQ Treatment Information for Patients''' | ||
| + | <!--T:3--> | ||
*[[Types/liver/patient/adult-liver-treatment-pdq|Adult Primary Liver Cancer Treatment]] | *[[Types/liver/patient/adult-liver-treatment-pdq|Adult Primary Liver Cancer Treatment]] | ||
| + | <!--T:4--> | ||
*[[Types/liver/patient/bile-duct-treatment-pdq|Bile Duct Cancer (Cholangiocarcinoma) Treatment]] | *[[Types/liver/patient/bile-duct-treatment-pdq|Bile Duct Cancer (Cholangiocarcinoma) Treatment]] | ||
| + | <!--T:5--> | ||
*[[Types/liver/patient/child-liver-treatment-pdq|Childhood Liver Cancer Treatment]] | *[[Types/liver/patient/child-liver-treatment-pdq|Childhood Liver Cancer Treatment]] | ||
| + | <!--T:6--> | ||
'''View more information''' | '''View more information''' | ||
| + | <!--T:7--> | ||
*[[Types/childhood-cancers/late-effects-pdq|Late Effects of Treatment for Childhood Cancer (PDQ®)]] | *[[Types/childhood-cancers/late-effects-pdq|Late Effects of Treatment for Childhood Cancer (PDQ®)]] | ||
| + | <!--T:8--> | ||
*[[About-cancer/treatment/drugs/liver|Drugs Approved for Liver Cancer]] | *[[About-cancer/treatment/drugs/liver|Drugs Approved for Liver Cancer]] | ||
| + | <!--T:9--> | ||
*[[About-cancer/treatment/clinical-trials/search|Find NCI-Supported Clinical Trials]] | *[[About-cancer/treatment/clinical-trials/search|Find NCI-Supported Clinical Trials]] | ||
</translate> | </translate> | ||
| + | <comments /> | ||
Latest revision as of 16:28, 25 December 2019
Liver and Bile Duct Cancer
Liver cancer includes hepatocellular carcinoma (HCC) and bile duct cancer (cholangiocarcinoma). Risk factors for HCC include chronic infection with hepatitis B or C and cirrhosis of the liver. Explore the links on this page to learn more about liver cancer treatment, prevention, screening, statistics, research, and clinical trials.
PDQ Treatment Information for Patients
View more information
Enable comment auto-refresher